Clinical Manifestations, Laboratory Findings, and Treatment Outcomes of SARS Patients

Emerging Infectious Diseases

Volumn 10, Issue 5, 2004, Pages 818-824

  Wang, Jann Tay ^a   Sheng, Wang Huei ^a   Fang, Chi Tai ^a   Chen, Yee Chun ^a   Wang, Jiun Ling ^a   Yu, Chong Jen ^a   Chang, Shan Chwen ^a   Yang, Pan Chyr ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; C REACTIVE PROTEIN; CREATINE KINASE; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; RIBAVIRIN; STEROID;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COUGHING; DEATH; DIARRHEA; DISEASE EXACERBATION; DYSPNEA; FATALITY; FEMALE; FEVER; HUMAN; LABORATORY TEST; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MYALGIA; PNEUMONIA; PROSPECTIVE STUDY; SEVERE ACUTE RESPIRATORY SYNDROME; SYMPTOMATOLOGY; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 2142809650     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1005.030640     Document Type: Article

References (27)

1. World Health Organization. SARS epidemiology to date [monograph on the Internet]. 2003. [cited April 11, 2003]. Available from: http://www.who.int/csr/sars/epi2003_04_11/en/
2. World Health Organization Multicentre Collaborative Network for Severe Acute Respiratory Syndrome (SARS) Diagnosis. A multicentre collaboration to investigate the cause of severe acute respiratory syndrome. Lancet 2003;361:1730-3.
3. World Health Organization. Cumulative number of reported probable cases of severe acute respiratory syndrome (SARS) [monograph on the Internet]. [cited July 11, 2003]. Available from: http://www.who.int/csr/sars/country/en
4. Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003;348:1986-94.
5. Peiris JSM, Chu CM, Cheng VCC, Chan KS, Hung IFN, Poon LLM, et al. Clinical progression and viral load in a community-outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003;361:1767-72.
6. So LKY, Lau ACW, Yan LYC, Cheung TMT, Poon F, Yung RWH, et al. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet 2003;361:1615-7.
7. World Health Organization. Severe acute respiratory syndrome (SARS): multi-country outbreak updated 34 [monograph on the Internet]. [cited May 5, 2003]. Available from: http://www.who.int/csr/don/2003_04_19/en/
8. Moss M, Ingram RH Jr. Acute respiratory distress syndrome. In: Braunwald E, Fauci AS, Kasper DL, Hauser ST, Longo DI, Jameson JL, editors. Harrison's principles of internal medicine. 15th ed. Washington: McGraw-Hill Medical Publishing Division; 2001. p. 1523-6.
9. Centers for Disease Control and Prevention. International SARS case report form [monograph on the Internet]. [cited Mar 27, 2003]. Available from: http://www.cdc.gov/ncidod/sars/pdf/intcasereport-form-sars.pdf
10. Kreger BE, Craven DE, McCabe WR. Gram-negative bacteremia. Am J Med 1980;68:344-55.
11. Centers for Disease Control and Prevention. Severe acute respiratory syndrome-Taiwan, 2003. MMWR Morb Mortal Wkly Rep 2003;52:461-4.
12. Cheung CY, Poon LL, Lau AS, Luk W, Lau YC, Shortridge KF, et al. Induction of postinflammatory cytokines in human macrophages by influenza A (H5N1) virus: a mechanism for the unusual severity of human disease? Lancet 2002;360:1831-7.
13. Hooton TM, Haley RW, Culver DH, White JW, Morgan WM, Carroll RJ. The joint associations of multiple risk factors with the occurrence of nosocomial infection. Am J Med 1981;70:960-70.
14. Hsueh PR, Chen PJ, Hsiao CH, Yeh SH, Cheng WC, Wang JL, et al. Patient data, early SARS epidemic, Taiwan. Emerg Infect Dis 2004;10: in press.
15. Freeman B, Rathore MH, Salman E, Joyce MJ, Pitel P. Intravenously administered immune globulin for the treatment of infection-associated hemophagocytotic syndrome. J Pediatr 1993;123:479-81.
16. Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003;289:2801-9. [erratum JAMA 2003;290:334].
17. Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003;289:2801-9. [erratum JAMA 2003;290:334].
18. Tillet WS, Francis T. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med 1941;73:173-82.
19. Johnson HL, Chiou CCC, Cho CT. Applications of acute phase reactants in infectious diseases. J Microbiol Immunol Infect 1999;32:73-82.
20. Lloyd-Jones DM, Levy D, Brezis M, Evans MK, Zonderman AB, Johnson WR, et al. C-reactive protein in the prediction of cardiovascular events. N Engl J Med 2003;348:1059-61.
21. Singh U, Scheld WM. Infectious etiologies of rhabdomyolysis: three case reports and review. Clin Infect Dis 1996;22:642-9.
22. Gabow PA, Kaehny WD, Kelleher SP. The spectrum of rhabdomyolysis. Medicine 1982;61:141-52.
23. Wang JL, Wang JT, Yu CJ, Chen YC, Hsueh PR, Hsiao CH, et al. Rhabdomyolysis associated with probable SARS. Am J Med 2003115:421-2.
24. Berger JR. Sabet A. Infectious myelopathies. Semin Neurol 2002;22:133-42.
25. McEvoy GK. AHFS Drug Information 2003. Bethesda: American Society of Health-System Pharmacists; 2003.
26. Hund EF, Fogel W, Krieger D, DeGeorgia M, Hacke W. Critical illness polyneuropathy: clinical findings and outcomes of a frequent cause of neuromuscular weaning failure. Crit Care Med 1996;24:1328-33.
27. National Taiwan University Hospital. Nosocomial infection surveillance, 2001. Taipei: National Taiwan University Hospital; 2002.